Cite
HARVARD Citation
Aussedat, G. et al. (2022). Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study. Leukemia & lymphoma. 63 (3), pp. 599-607. [Online].